Research
SARS2BlockEntry: using proteins to prevent the virus from entering cells.
… the entry of SARS-CoV-2 into target cells. The work should lead to the development of antiviral drugs targeting … we could advance the research," explains Bernard Delmas, leader of the SARSBlockEntry project. The project is based … in vivo (in a mouse infection model). Work is already underway. The first step is to produce the RBD so that it can be …
Published on: